These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 12711119

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Comparable efficacy and safety of COVID-19 vaccines for patients receiving tegafur-uracil as postoperative adjuvant chemotherapy.
    Nishikubo M, Tanaka Y, Mitsui S, Doi T, Hokka D, Hojo W, Sakai H, Funakoshi Y, Yakushijin K, Ohji G, Minami H, Maniwa Y.
    Surg Today; 2023 Sep; 53(9):1057-1063. PubMed ID: 36752867
    [Abstract] [Full Text] [Related]

  • 24. Alpha-actinin-4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomas.
    Noro R, Honda K, Nagashima K, Motoi N, Kunugi S, Matsubayashi J, Takeuchi S, Shiraishi H, Okano T, Kashiro A, Meng X, Yoshida Y, Watanabe S, Usuda J, Inoue T, Wilber H, Ikeda N, Seike M, Gemma A, Kubota K.
    Cancer Sci; 2022 Mar; 113(3):1002-1009. PubMed ID: 34845792
    [Abstract] [Full Text] [Related]

  • 25. Impact of pathological stage and histological subtype on clinical outcome of adjuvant chemotherapy of paclitaxel plus carboplatin versus oral uracil-tegafur for non-small cell lung cancer: subanalysis of SLCG0401 trial.
    Soh J, Toyooka S, Okumura N, Nakamura H, Nakata M, Yamashita M, Sakamoto J, Aoe M, Hotta K, Morita S, Date H.
    Int J Clin Oncol; 2019 Nov; 24(11):1367-1376. PubMed ID: 31312931
    [Abstract] [Full Text] [Related]

  • 26. Feasibility Trial of Oral UFT after Platinum-based Adjuvant Chemotherapy in Patients with Resected Non-small Cell Lung Cancer.
    Sawada S, Sugimoto R, Ueno T, Yamashita M.
    Acta Med Okayama; 2017 Dec; 71(6):513-518. PubMed ID: 29276224
    [Abstract] [Full Text] [Related]

  • 27. [Efficacy of postoperative adjuvant therapy for resected non-small cell lung cancer--an evidence-based review].
    Tanaka F, Wada H.
    Gan To Kagaku Ryoho; 2006 Mar; 33(3):300-6. PubMed ID: 16531708
    [Abstract] [Full Text] [Related]

  • 28. Final analyses of the prospective controlled trial on the efficacy of uracil and tegafur/leucovorin as an adjuvant treatment for stage II colon cancer with risk factors for recurrence using propensity score-based methods (JFMC46-1201).
    Ogata Y, Sadahiro S, Sakamoto K, Tsuchiya T, Takahashi T, Ohge H, Sato T, Kondo K, Baba H, Itabashi M, Ikeda M, Hamada M, Maeda K, Masuko H, Takahashi K, Kusano M, Hyodo I, Sakamoto J, Taguri M, Morita S.
    Int J Clin Oncol; 2024 Sep; 29(9):1284-1292. PubMed ID: 38833114
    [Abstract] [Full Text] [Related]

  • 29. A feasibility study of postoperative adjuvant chemotherapy with fluoropyrimidine S-1 in patients with stage II-IIIA non-small cell lung cancer.
    Tsuboi M, Kondo K, Takizawa H, Kawakita N, Sawada T, Toba H, Kawakami Y, Yoshida M, Ishikura H, Kimura S, Tangoku A.
    J Med Invest; 2018 Sep; 65(1.2):90-95. PubMed ID: 29593202
    [Abstract] [Full Text] [Related]

  • 30. Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial.
    Hasegawa K, Saiura A, Takayama T, Miyagawa S, Yamamoto J, Ijichi M, Teruya M, Yoshimi F, Kawasaki S, Koyama H, Oba M, Takahashi M, Mizunuma N, Matsuyama Y, Watanabe T, Makuuchi M, Kokudo N.
    PLoS One; 2016 Sep; 11(9):e0162400. PubMed ID: 27588959
    [Abstract] [Full Text] [Related]

  • 31. Toxicity and Efficacy of Sequential Chemotherapy in Patients with p-stage I Non-small Cell Lung Cancer that Recurring during Postoperative Tegafur-Uracil Adjuvant Chemotherapy.
    Kashiwabara K, Semba H, Fujii S, Tsumura S.
    Cancer Invest; 2018 Sep; 36(8):424-430. PubMed ID: 30234395
    [Abstract] [Full Text] [Related]

  • 32. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.
    Kato H, Ichinose Y, Ohta M, Hata E, Tsubota N, Tada H, Watanabe Y, Wada H, Tsuboi M, Hamajima N, Ohta M, Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy.
    N Engl J Med; 2004 Apr 22; 350(17):1713-21. PubMed ID: 15102997
    [Abstract] [Full Text] [Related]

  • 33. [A randomized controlled study of post-operative adjuvant therapy in non-small cell lung cancer].
    Fukushima M, Tsushima T, Ito H, Fukuda Y, Maruyama A, Fujita H, Yagihashi N, Tsuge T, Ishioka T, Kudo T, Kishibe S, Sato T, Machida S, Kogawa R, Takashima K, Koie H, Fujita K.
    Gan To Kagaku Ryoho; 1996 Feb 22; 23(3):303-9. PubMed ID: 8712823
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Tegafur-uracil plus gemcitabine combination chemotherapy in patients with advanced non-small cell lung cancer previously treated with platinum.
    Seto T, Yamanaka T, Nakano M, Ota M, Maruyama R, Okamoto T, Wataya H, Uematsu K, Seki N, Eguchi K, Semba H, Ichinose Y.
    J Thorac Oncol; 2008 Jun 22; 3(6):637-42. PubMed ID: 18520804
    [Abstract] [Full Text] [Related]

  • 36. UFT plus cisplatin combination chemotherapy in the treatment of patients with advanced nonsmall cell lung carcinoma: a multiinstitutional phase II trial. For the Japan UFT Lung Cancer Study Group.
    Ichinose Y, Yosimori K, Yoneda S, Kuba M, Kudoh S, Niitani H.
    Cancer; 2000 Jan 15; 88(2):318-23. PubMed ID: 10640963
    [Abstract] [Full Text] [Related]

  • 37. [Adjuvant chemotherapy for non-small cell lung cancer].
    Otake Y, Tanaka F, Wada H, Hitomi S.
    Gan To Kagaku Ryoho; 1997 Aug 15; 24(10):1245-51. PubMed ID: 9279343
    [Abstract] [Full Text] [Related]

  • 38. Administration of adjuvant oral tegafur/uracil chemotherapy post hepatocellular carcinoma resection: A randomized controlled trial.
    Ishizuka M, Kubota K, Nemoto T, Shimoda M, Kato M, Iso Y, Tago K.
    Asian J Surg; 2016 Jul 15; 39(3):149-54. PubMed ID: 26123137
    [Abstract] [Full Text] [Related]

  • 39. Prognostic significance of p53 status in non-small cell lung cancer in correlation with postoperative adjuvant therapy.
    Hanaoka N, Tanaka F, Wada H.
    Thorac Cardiovasc Surg; 2002 Dec 15; 50(6):355-9. PubMed ID: 12457313
    [Abstract] [Full Text] [Related]

  • 40. UFT (tegafur and uracil) as postoperative adjuvant chemotherapy for solid tumors (carcinoma of the lung, stomach, colon/rectum, and breast): clinical evidence, mechanism of action, and future direction.
    Tanaka F.
    Surg Today; 2007 Dec 15; 37(11):923-43. PubMed ID: 17952521
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.